Taejon-si, South Korea

Sun Kyung Lee




Average Co-Inventor Count = 11.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Taegon-si, KR (2001)
  • Taejon-si, KR (2002 - 2008)
  • Taejeon-si, KR (2007 - 2008)

Company Filing History:


Years Active: 2001-2008

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Sun Kyung Lee

Introduction

Sun Kyung Lee is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that protect the heart from ischemia-reperfusion injury. With a total of 6 patents to his name, his work has the potential to impact the treatment of various heart-related diseases.

Latest Patents

One of his latest patents involves benzopyran derivatives substituted with a thioxobenzoxazole derivative, along with their pharmaceutically acceptable salts and compositions. This invention focuses on protecting the heart from ischemia-reperfusion both in vivo and in vitro. The pharmaceutical composition containing these derivatives can be effectively used for protecting tissues influenced by ischemia-reperfusion, including the heart, nervous cells, and brain.

Another significant patent by Sun Kyung Lee is related to furancarbonylguanidine derivatives. This invention includes a preparation method and a pharmaceutical composition that inhibits NHE-1 (sodium-hydrogen exchanger isoform 1). These derivatives have shown promise in recovering heart function damaged from ischemia/reperfusion and can be used for preventing and treating ischemic heart diseases such as myocardial infarction and arrhythmia.

Career Highlights

Throughout his career, Sun Kyung Lee has worked with reputable organizations, including Dongbu Hannong Chemical Co., Ltd. and the Korea Research Institute of Chemical Technology. His experience in these companies has contributed to his expertise in chemical technology and pharmaceutical development.

Collaborations

Sun Kyung Lee has collaborated with notable colleagues, including Kyu Yang Yi and Jee Hee Suh, who is a woman. These collaborations have likely enriched his research and development efforts in the pharmaceutical field.

Conclusion

Sun Kyung Lee's innovative work in developing pharmaceutical compounds demonstrates his commitment to advancing medical science. His contributions have the potential to significantly improve treatments for heart diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…